Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

Ear ulceration, in discoid LE, 1712
Early arthritis, Chlamydia trachomatis in synovial membranes and, 1410
Early joint disease, joint space measurement in hand radiographs using computerized image analysis and, 890
Early JRA, IL-1α polymorphism in, 221
Early juvenile DM, enteroviral RNA, bacterial DNA and, in juvenile DM, 1513
Early OA
experimental, aggrecan and type II collagen genes in, 420
familial, COL2A1 gene mutation in, 999
Early RA
antibodies to synovial antigens in, 1418
anti-CD4 monoclonal antibody in, 1457
bone mineral density in, 1204
radiologic damage and joint inflammation in, 1466
Early response genes, cytokines and, 877
Eating disorders
acute parvovirus B19-induced pancytopenia, MTX and, in RA, 1023
sexual abuse, physical abuse and, in fibromyalgia, 161, 229, 235
Echotexture, fibrillar, in ultrasonography of finger tendons in RA, 786
Ecology, Lyme borreliosis and, 565
Economic factors
in SLE, 267, 274
in social and psychological impact of musculoskeletal conditions, 1351
Economic status, sexual abuse, physical abuse and, in fibromyalgia, 161, 229, 235
Ectopic pregnancy, immunosuppressive drugs during pregnancy and, 1722
EDA, in fibronectin in RA synovium, 678
Edema, acute cerebral, in spin-spin relaxation of brain tissue in SLE, 810
Education level
morbidity in SLE and, 267
sexual abuse, physical abuse and, in fibromyalgia, 161, 229, 235
walking velocity in elderly and, 343
Effusions
joint and connective tissue ultrasonography and, 736
knee, 284, 1541
EGTA, rheumatoid synovial fibroblast adhesion in cartilage and, 1694
18-kd histone-like protein, in pathogenesis of spondylarthropathies, 1547
Elastase, antineutrophil cytoplasmic antibodies in SLE and, 633
Elastin, collagen degradation and, in SSc, 517
Elderly
anemia in giant cell arteritis in, 434
chondrocytes in, 960
cognitive deficits in rheumatic diseases and, 1363
degenerative lumbar spinal stenosis in, 1236
epidemiology of polymyalgia rheumatica in Olmsted County, MN and, 369
functional disability in PM/DM and, 1218
homebound, 343
joint and connective tissue ultrasonography in, 736
Lyme disease with DM symptoms in, 1157
monoclonal antibodies in detection of biochemical markers of arthritis and, 655
OA in, 907, 1134, 1500
prevalence and characteristics of fibromyalgia and, 5
RA in, 315, 334
risk factors for septic arthritis in joint disease and, 1819
survival in SLE and, 274
walking velocity in, 343
Electroencephalography, sleep, amitriptyline and, in fibromyalgia, 1211
Electrokinetic coupling coefficient, stromelysin degradation of cartilage and, 1678
Electromechanics, stromelysin degradation of cartilage and, 1678
Electromyography, in Lyme disease with DM symptoms in elderly, 1157
Electron microscopy
to study apoptosis in RA synoviocytes, 485
to study pseudoseptic inflammatory knee effusion in sickle cell disease, 284
Electrophoresis
agarose gel, 485
agarose-polyacrylamide gel, 525
denaturing gradient gel, 999
in OA, 525, 660, 999
in RA, 660, 1194
Electrophoretic mobility, cytokines, early response genes and, 877
Elementary body antigens, Chlamydia trachomatis in synovial membranes and, 1410
Embryotoxicity, immunosuppressive drugs during pregnancy and, 1722
Emotional factors, cognitive deficits in rheumatic diseases and, 1363
Employment, work disability in RA and, 1630
Encephalomyelitis, experimental allergic, autoimmune disease induction by microbial pathogens and, 458
End-stage liver disease, α1-antitrypsin deficiency, MTX and, 1014
End-stage OA, cardiovascular fitness and health in, 799
Endogenous IL-10, RF-secreting B cells in RA and, 1771
Endogenous immunosuppression, IL-10 production by synovial T cells and, 946
Endogenous retroviruses
autoimmune disease induction by microbial pathogens and, 458
HRES-1 antibodies and, in SLE and overlap syndromes, 1660
Endoscopy and NSAID
in gastroduodenal injury in children, 1225
gastrointestinal tract and, 5
Endothelial cells
E-selectin in RA and, 750
nitric oxide and lipoxin A4 in polymorphonuclear cell vascular cytotoxicity and, 768
in SSc, 184, 406
umbilical vein, in Lyme borreliosis, 565
Endothelium
nitric oxide and lipoxin A4 in polymorphonuclear cell vascular cytotoxicity and, 768
nuclear factor-κB in rheumatoid synovium and, 1762
Raynaud's phenomenon, scleroderma and, 1
Enteric infection, autoimmune disease induction by microbial pathogens and, 458
Enterocolitis, gold-induced, HLA-DRB1*0404 allele and, 755
Enteropathogenic yersiniae, Yersinia enterocolitica binding of adhesin YadA to collagen and, 1283
Enteropathy, NSAID, gastrointestinal tract and, 5
Enterotoxin D, staphylococcal, autoimmune disease induction by microbial pathogens and, 458
Enteroviral RNA, in juvenile DM, 1513
Enthesopathy, pediatric AS and, 835
Envelope protein, HTLV gp46, HTLV-1 in PM and, 690
Environmental factors
autoimmune disease induction by microbial pathogens and, 458
bone mass and, 61
in geographic clusters of SLE, 1564
guidelines for clinical trials in SSc and, 351
Enzyme immunoassay
sandwich, to study stromelysin-1 and TIMP-1 in RA, 969
to study antigen-based heteropolymers, 190
Enzyme-linked immunosorbent assay (ELISA)
in JRA, 211, 1531, 1735
Mi-2 autoantigen in DM and, 1389
micro-, to study cross-reactivity of anticardiolipin autoantibodies with oxidized low-density lipoprotein, 1382
in overlap syndromes, 1660
in pediatric Lyme arthritis in Europe, 361
in RA, 96, 678, 946, 1046, 1107, 1771
serum soluble Fas/APO-1 in autoimmune disease and, 1738
in SLE, 633, 1055, 1485, 1655, 1660, 1735
in SSc, 184, 406, 985
to study anti-U1 RNA antibodies in connective tissue disease and, 1837
to study glycosaminoglycan epitopes in knee joint fluid after trauma, 953
to study HRES antibodies, 1660
to study HTLV-1 in PM, 690
to study p4 peptide binding to DRB1*0401, 1744
to study SS-A/Ro 52-kd molecule epitopes, 990
to study stromelysin degradation of cartilage, 173
Enzymes
Arg-Gly-Asp (RGD) peptide, IL-1 and, in chondrocyte metalloproteinase synthesis, 1304
cyclooxygenase, NSAID, gastrointestinal tract and, 5
joint destruction in HIV infection and, 1328
liver, 1799
nitric oxide and lipoxin A4 in polymorphonuclear cell vascular cytotoxicity and, 768
in OA, 976, 1290
purine, 142
in RA, 142, 976, 1324, 1799
Yersinia enterocolitica binding of adhesin YadA to collagen and, 1283
Eosinophil major basic protein, in SSc, 939
Eosinophilia, in hydatid disease in chronic monarthritis, 1338
Eosinophilia-myalgia syndrome, cognitive deficits in rheumatic diseases and, 1363
Eosinophilic fasciitis, carpal tunnel syndrome due to T cell lymphomas and, 1707
Epidemiologic studies
guidelines for medical management of OA and, 1535, 1541
Lyme borreliosis, 565
polymyalgia rheumatica in Olmsted County, MN, 369
RA Disease Activity Index in, 795
silicone breast implants and scleroderma, 719
of SLE, 1564
Epidermal growth factor, cytokines, early response genes and, 877
Epidermal necrolysis, toxic, after sulfasalazine in psoriatic arthritis, 573
Epineural vasculitis, peripheral neuropathy with necrotizing vasculitis in RA and, 1618
Epithelial cells, in pathogenesis of spondylarthropathies, 1547
Epitheliopathy, acute posterior multifocal placoid pigment, in systemic JRA, 446
Epitopes
aggrecan, 660
auto-, SS-A/Ro 52-kd molecule, 990
autoimmune disease induction by microbial pathogens and, 458
cross-reactive, 1660
glycosaminoglycan, in knee joint fluid after trauma, 953
HRES-1 antibodies and, 1660
MA1, anti-apolipoprotein A1 in SLE and, 1655
MHC class II genes, anti-U1 snRNP antibody and, 396
monoclonal antibodies in detection of biochemical markers of arthritis and, 655
in OA, 78, 660
in pathogenesis of spondylarthropathies, 1547
in RA, 660, 1754
shared, 1754
in SLE, 1655, 1660
T cell, mapping of U1-A RNP by, 1170
VDIPEN, stromelysin degradation of cartilage and, 1678
Epstein-Barr virus, enteroviral RNA, bacterial DNA and, in juvenile DM, 1513
Epstein-Barr virus-associated Hodgkin's lymphoma, in RA after MTX and cyclosporine, 867
Equilibrium, stromelysin degradation of cartilage and, 1678
Ergonometry, cardiovascular fitness in end-stage OA and, 799
Erosions
cartilage, tenidap and, in experimental canine OA, 1290
NSAID, gastrointestinal tract and, 5
Erosive arthritis, HLA type in MCTD and, 259
Erosive RA, acute parvovirus B19-induced pancytopenia, MTX and, 1023
Erythema, in Lyme disease with DM symptoms in elderly, 1157
Erythema migrans
Lyme borreliosis and, 565
in pediatric Lyme arthritis in Europe, 361
Erythrocyte sedimentation rate
clodronate-containing liposomes, macrophages and, in rat adjuvant arthritis, 1777
evaluative laboratory testing and, 1555
in JRA, 211, 221, 1531
in RA, 29, 601, 819, 969, 1031, 1568
vitamin B6 in rheumatoid cachexia and, 105
Erythrocytes
antigen-based heteropolymers and, 190
in azathioprine toxicity in RA, 142
bone marrow fat, in inflammation in sickled erythrocytes, 1349
in Lyme borreliosis, 565
in pseudoseptic inflammatory knee effusion in sickle cell disease, 284
in rheumatoid vasculitis, 248
sickled, pseudoseptic inflammatory knee effusions caused by, 284
vitamin B6 in rheumatoid cachexia and, 105
Escherichia coli
Klebsiella pneumoniae-reactive T cells in blood in AS and, 1277
SS-A/Ro 52-kd epitopes and, 990
E-selectin
in Lyme borreliosis, 565
in RA, 750
soluble, 184
in SSc, 184, 406
Esophageal dysmotility, diltiazem in calcinosis and, 1640
Esophagus
in atrial myxoma and cutaneous PAN with Crohn's disease, 1161
NSAID, gastrointestinal tract and, 5
Estrogen, tapering, bone turnover and bone mass after, 292
Ethanol, NSAID, gastrointestinal tract and, 5
Ethidium bromide staining, to study aggrecan and type II collagen genes in experimental OA, 420
Ethnic studies
prevalence and incidence of SLE in Birmingham, England, 551
sexual abuse and physical abuse in fibromyalgia, 161, 229, 235
Etidronate, in Paget's disease of bone, 851
Eukaryotes, in pathogenesis of spondylarthropathies, 1547
Eukaryotic protein, IgG receptors in autoimmune disease and, 306
Every-other-week MTX, in RA, 601, 1865
Exchange transfusions, immunosuppressive drugs during pregnancy and, 1722
Exercise
aerobic conditioning, 1535, 1541
factors affecting bone mass and, 61
MRI/MRS in DM and, 68
in OA, 525, 799, 1535, 1541
Exocrine glands, cognitive deficits in rheumatic diseases and, 1363
Exogenous IL-4, IL-6, in RA, 1046
Exogenous IL-10, in RA, 1046, 1771
Exons, COL2A1 gene mutations in chondrodysplasias and familial OA and, 999
Experimental allergic encephalomyelitis, autoimmune disease induction by microbial pathogens and, 458
Experimental antiphospholipid syndrome, transfer of, by bone marrow cell transplantation, 115
Experimental arthritis
radiographic changes in adjuvant arthritis in rats, 129
somatostatin in, 1687
Experimental bacterial cell wall-induced arthritis, autoimmune disease induction by microbial pathogens and, 458
Experimental drugs, draft guidelines for drugs in JRA clinical trials and, 715
Experimental OA
aggrecan and type II collagen genes in, 420
canine, 525, 1290
rabbit, calcium pyrophosphate microcrystalline synovitis and, 201
Experimental vasculitis, antineutrophil cytoplasmic antibodies in mice and, 1375
Expired respiratory gases, cardiovascular fitness in end-stage OA and, 799
Extensor tendon, ultrasonography of, 736, 786
Extraarticular features of RA, erythrocytes and, 248
Extracellular adenosine, antiinflammatory mechanism of regulators of, 1040
Extracellular domains, IgG receptors in autoimmune disease and, 306
Extracellular elementary bodies, Chlamydia trachomatis in synovial membranes and, 1410
Extracellular matrix, synovitis, protein clearance and, in canine knee, 1085
Extracellular nitric oxide, lipoxin A4 and, in polymorphonuclear cell vascular cytotoxicity and, 768
Extracellular pathogens, in pathogenesis of spondylarthropathies, 1547
Extracellular tissue deposition of eosinophil major basic protein, in SSc, 939
Extremities
lower, cardiovascular fitness and health in end-stage OA and, 799
in peripheral neuropathy with necrotizing vasculitis in RA, 1618
upper, in pediatric AS, 835
Exudative tenosynovitis, ultrasonography of finger tendons in RA and, 786
Eye
in JRA, 221, 446
Lyme borreliosis and, 565